Drugs / UPREVSTOBART
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04989387 | Oct 2021 → Sep 2024 | digestive system cancer, head and neck squamous cell carcinoma | Incyte Corporation | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UPREVSTOBART | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314890 ↗ |
| Known as | INCA00186 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04989387 ↗ |
| Modality | Monoclonal antibody | — CHEMBL5314890 ↗ |